Skip to content

Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialty.

Tarunya Arun, Kate Petheram, Emma Tallantyre, Helen Ford, Jeremy Chataway, Niall Mac Dougall, Anisha Doshi, Christina Englezou, Rachel Farrell, Stella Hughes, Gavin McDonnell, Katy Murray, Richard Rees, Neil Robertson, Klaus Schmierer, Ruth Dobson

Multiple sclerosis and related disorders December 1, 2024 DOI: 10.1016/j.msard.2024.106144 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Population Neurology trainees in the UK
Topics DMT
Keywords Medical-education Neurological-training Multiple-sclerosis-care Specialist-workforce-development Clinical-mentorship Multiple sclerosis Neuroinflammation Neurology Subspecialist experience
Key findings Significant gaps exist in training for neuroinflammatory disorders, including insufficient opportunities, lack of mentorship, and concerns about managing complex treatments.

Abstract

Therapeutics of neuroinflammatory disorders including multiple sclerosis is one of the fastest growing areas in neurology. However, pressures on higher specialty training in neurology together with an expanding curriculum have led to challenges in adequately preparing trainees for a subspecialist career. In this study we set out to understand current perceptions and barriers to training in neuroinflammatory disorders among neurology trainees in the UK. A structured questionnaire was used to assess trainees' perspectives on training opportunities and career aspirations. Findings reveal significant gaps in training, including insufficient training opportunities, lack of mentorship, and concerns about managing complex treatment regimes. We used these findings to develop structured action points with aim of improving training and retention in this subspecialty. These include early exposure to subspecialty experiences, enhanced mentorship, and equal access to training opportunities regardless of geographical location. Our findings underscore the need for further curriculum development in neurology training, potentially combining early support with dedicated fellowships later in training, in order to ensure sustainability of neuroinflammation as a subspecialty and to meet the growing demand for expertise in MS and related conditions.

Comparable studies

Other cross-sectional and survey studies on DMT, most cited first.

Study Year Design Participants
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT Adults reporting a single most memorable God encounter experience, either nondrug or... 2019 Cross-sectional survey n = 4,285
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. People who had a memorable entity encounter after taking N,N-dimethyltryptamine 2020 Survey n = 2,561
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Adults who use 5-MeO-DMT, recruited via internet-based advertisements; predominantly... 2018 Cross-sectional survey n = 515
Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample People who completed the Global Drug Survey online in 2012, many of whom have used drugs 2013 Cross-sectional survey n = 22,289

Explore topics